Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Amortizatization of Intangibles: 2012-2024

Historic Amortizatization of Intangibles for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Dec 2024 value amounting to $24.7 million.

  • Amphastar Pharmaceuticals' Amortizatization of Intangibles rose 1.46% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.0 million, marking a year-over-year increase of 0.97%. This contributed to the annual value of $24.7 million for FY2024, which is 92.66% up from last year.
  • Latest data reveals that Amphastar Pharmaceuticals reported Amortizatization of Intangibles of $24.7 million as of FY2024, which was up 92.66% from $12.8 million recorded in FY2023.
  • Amphastar Pharmaceuticals' 5-year Amortizatization of Intangibles high stood at $24.7 million for FY2024, and its period low was $3.3 million during FY2021.
  • Its 3-year average for Amortizatization of Intangibles is $13.7 million, with a median of $12.8 million in 2023.
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first dropped by 10.59% in 2021, then spiked by 265.94% in 2023.
  • Yearly analysis of 5 years shows Amphastar Pharmaceuticals' Amortizatization of Intangibles stood at $3.7 million in 2020, then dropped by 10.59% to $3.3 million in 2021, then increased by 7.35% to $3.5 million in 2022, then soared by 265.94% to $12.8 million in 2023, then surged by 92.66% to $24.7 million in 2024.